QUIAPEG
LIVE

Serial Number

79271613

Owner

QuiaPEG Pharmaceuticals AB

Attorney

Cynthia Johnson Walden

Filing Date

Sep 2, 2019

Add to watchlist:

No watchlists yet
View on USPTO

QUIAPEG Trademark

Serial Number: 79271613 • Registration: 6187216

QUIAPEG is a trademark filed by QuiaPEG Pharmaceuticals AB on September 2, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

QuiaPEG Pharmaceuticals AB (4 trademarks)

Virdings Allé 32 B
Uppsala SE-754 50 , SE

Entity Type: 03

Trademark Details

Filing Date

September 2, 2019

Registration Date

November 3, 2020

Published for Opposition

August 18, 2020

Goods & Services

Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances

Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations, reagents and substances, and of diagnostic preparations, reagents and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services

Reagents for scientific and research use, Diagnostic preparations for scientific or research use, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 3, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 7, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 12, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 12, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 3, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 3, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Aug 18, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 13, 2020 CNSA
ATTORNEY REVIEW COMPLETED
Jul 13, 2020 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jul 9, 2020 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jun 19, 2020 LIMG
TEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2020 CRFA
ASSIGNED TO LIE
May 28, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2020 TROA
REFUSAL PROCESSED BY IB
Mar 7, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 15, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 22, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 21, 2020 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Dec 5, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 5, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 4, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 19, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 14, 2019 REPR